Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan.

Autor: Egami, Akemi1 (AUTHOR), Takahashi, Shinji1 (AUTHOR), Kokubo, Takeshi1 (AUTHOR), Boggarapu, Sreedevi2 (AUTHOR), Beresford, Eric2 (AUTHOR) eric.beresford@nobelpharma-us.com
Zdroj: Dermatology & Therapy. May2023, Vol. 13 Issue 5, p1113-1126. 14p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje